Trials / Completed
CompletedNCT02236026
A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers
A Double-Blind, Placebo-Controlled, Randomized, Crossover Design Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers: A Thorough QT/QTc Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Population Council · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the effect of Nestorone (NES) administered as an bolus injection on the corrected QT interval using Fridericia's formula (QTcF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Supratherapuetic dose of Nestorone | |
| DRUG | Placebo | |
| DRUG | Moxifloxacin |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-09-10
- Last updated
- 2017-08-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02236026. Inclusion in this directory is not an endorsement.